This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Technology / 3billion Launches 3B-NEO Screening Service
Tech product launch

3billion Launches 3B-NEO Screening Service

Analysis based on 6 articles · First reported Jun 01, 2026 · Last updated Jun 01, 2026

Sentiment
70
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The launch of 3B-NEO by 3 Billion is expected to positively impact the biotechnology and healthcare sectors by introducing an advanced genomic screening service. This could lead to increased demand for genetic testing, potentially benefiting other companies in the precision medicine space and driving innovation in early disease detection.

Biotechnology Healthcare Medical Diagnostics
Event Summary

3 Billion, an AI-powered genomic diagnostics company, launched 3B-NEO, a premium genomic newborn screening service on June 1, 2026. This service screens 595 genes associated with childhood-onset conditions, aiming to identify genetic risks before symptoms appear to enable earlier medical intervention. 3B-NEO offers both Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS) options, with results delivered within approximately two weeks. The service is designed for various healthcare providers and families globally, expanding 3 Billion's precision medicine platform beyond rare disease diagnosis into proactive newborn health management. 3 Billion is also establishing a U.S. subsidiary in United States — Austin, Texas to support its growth strategy.

Entities Involved
oth
3 Billion
3 Billion launched its new genomic newborn screening service, 3B-NEO, expanding its precision medicine platform and potentially increasing its market share and revenue.
Importance 100.0 Sentiment 75.0
oth
Changwon
As CEO of 3 Billion, Changwon announced the launch of 3B-NEO, highlighting the company's commitment to early genetic intervention and improved health outcomes.
Importance 80.0 Sentiment 70.0
cnt
United States
The United States is a key market for 3 Billion's growth strategy, with the company establishing a subsidiary and preparing laboratory operations in United States — Austin, Texas.
Importance 30.0 Sentiment 0.0
loc
United States — Austin, Texas
United States — Austin, Texas is the location where 3 Billion established its U.S. subsidiary and is preparing local laboratory operations to support healthcare providers and patients.
Importance 20.0 Sentiment 0.0
loc
Europe
Europe is mentioned as a region where genomic newborn screening is gaining clinical validation through research initiatives and pilot programs, indicating a growing market for 3 Billion's services.
Importance 20.0 Sentiment 0.0
cnt
South Korea
South Korea is the location of 3 Billion's headquarters, indicating its origin and base of operations.
Importance 10.0 Sentiment 0.0
Relationships
United States related ↔ South Korea
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.